Physician

Adam Hisham Hamawy, M.D.

According to 2025 Medicare claims, Adam Hamawy, M.D. (NPI: 1205015617) practices plastic and reconstructive surgery in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Somerset, NJ. This provider's primary affiliated billing organization is SAMRA PLASTIC AND RECONSTRUCTIVE SURGERY LLC (NPI: 1508804493; TIN: 204377711) and primary practice location at 08901-9998. Hamawy is affiliated with the Vytalize Health Enhanced ACO LLC (ACO ID: A5300), participating under the MSSP model.

Hamawy's data goes back to 2015 and runs through 2024. For example, in 2017, this provider had 19 traditional Medicare patients, billed 48 HCPCS/CPT codes, and received $12,742 in Medicare payments. 2024 Part D data shows 120 prescription claims across 24 beneficiaries totaling $1,456 in drug costs, led by Tobramycin-Dexamethasone (Tobramycin/Dexamethasone). Open Payments data shows 16 records totaling $563. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $884 to $1,456. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$14K$29K2015 Medicare payment: $28,564 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $20,016 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $12,742 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201542133$28,564
20162978$20,016
20171948$12,742
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.1K$4.2K2015 Drug cost: $884 (USD; Tot_Drug_Cst)2016 Drug cost: $470 (USD; Tot_Drug_Cst)2017 Drug cost: $289 (USD; Tot_Drug_Cst)2018 Drug cost: $581 (USD; Tot_Drug_Cst)2019 Drug cost: $642 (USD; Tot_Drug_Cst)2020 Drug cost: $1,707 (USD; Tot_Drug_Cst)2021 Drug cost: $4,235 (USD; Tot_Drug_Cst)2022 Drug cost: $3,112 (USD; Tot_Drug_Cst)2023 Drug cost: $3,623 (USD; Tot_Drug_Cst)2024 Drug cost: $1,456 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151434$884
20161132$470
2017N/R25$289
2018N/R34$581
2019N/R48$642
20201251$1,707
202138192$4,235
202234168$3,112
202335209$3,623
202424120$1,456

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Tobramycin-DexamethasoneTobramycin/Dexamethasone1499$473
Tranexamic AcidTranexamic Acid1632$351
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha12128$139
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1453$92
CephalexinCephalexin1995$69

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.16$563ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam Hisham Hamawy, M.D.?

Tedicare shows public-source Medicare data for Adam Hisham Hamawy, M.D. (NPI 1205015617), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Hisham Hamawy, M.D. have ACO affiliation data?

Adam Hisham Hamawy, M.D. is shown with ACO affiliation data for Vytalize Health Enhanced ACO LLC (MSSP, ACO ID A5300).

What billing organization is linked to Adam Hisham Hamawy, M.D.?

Adam Hisham Hamawy, M.D. is linked to SAMRA PLASTIC AND RECONSTRUCTIVE SURGERY LLC (billing NPI 1508804493) in the available physician profile data.

Does Adam Hisham Hamawy, M.D. have Open Payments data?

Adam Hisham Hamawy, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.